comprehensive
Previous article:
Moonlake's readout produced a cash windfall. Risks remain
Next article: Readout Newsletter: Merck, J&J, and long Covid
Next article: Readout Newsletter: Merck, J&J, and long Covid
hotspot
explore
-
FDA panel gives mixed vote on blood pressure devices
2025-09-30 08:42 -
Medicare explains how it will choose drugs for negotiation
2025-09-30 07:58 -
Prior authorization will have to move faster under new Biden rule
2025-09-30 07:12 -
Feds fine Medicare Advantage plans for overcharging members
2025-09-30 06:49 -
Parkinson’s finding may lead to tests and, someday, treatments
2025-09-30 06:35 -
Think you might have Covid
2025-09-30 06:34